José Ignacio Veytia-Bucheli

5PUBLICATIONS
15CO-AUTHORS
GlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)Organometallic chemistryBiomaterialsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 28, 2024
Differential Impact of CD43 and CD28 on T-Cell Differentiation Depending on the Order of Engagement with the TCR.

Monserrat Alba Sandoval-Hernández, Nora Alma Fierro, José Ignacio Veytia-Bucheli

|Dec 20, 2023
Thioarylation of 6-Amino-2,3,6-trideoxy-d-manno-oct-2-ulosonic Acid (IminoKdo): Access to 3,6-Disubstituted Picolinates and Mechanistic Insights.

Sujit Manmode, Nazar Hussain, Oscar Javier Gamboa Marin

|Jul 27, 2022
The Ca2+ Channel Blocker Verapamil Inhibits the In Vitro Activation and Function of T Lymphocytes: A 2022 Reappraisal.

José Ignacio Veytia-Bucheli, Den Alejandro Alvarado-Velázquez, Lourival Domingos Possani

Pageof 1